http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Foundation Medicine to Present at the Leerink Global Healthcare Conference
-
Foundation Medicine, Horizon Healthcare Services, Inc. and COTA Collaborate to Demonstrate the Benefits of a Precision Medicine Treatment Approach for Patients with Metastatic Non-Small Cell Lung Canc
-
Foundation Medicine (FMI) Prelim. Q4, FY15 Revenue Exceeds Expectations
-
Foundation Medicine Reports Preliminary 2015 Results and Provides 2016 Business Outlook, including Commercial Launch of its ctDNA Assay
-
Foundation Medicine Announces Presentations at the 2016 Genitourinary Cancers Symposium
-
Foundation Medicine to Present at the 34th Annual J.P. Morgan Healthcare Conference
-
Foundation Medicine And Mirati Therapeutics Collaborate To Develop A Companion Diagnostic For Glesatinib (MGCD265) In Non-Small Cell Lung Cancer (NSCLC)
-
Foundation Medicine Announces National Agreement with UnitedHealthcare for FoundationOne® in Metastatic Non-Small Cell Lung Cancer
-
Foundation Medicine Announces Presentations at the 2015 San Antonio Breast Cancer Symposium
-
Foundation Medicine to Present at the Goldman Sachs SMID Cap Growth Conference
-
Foundation Medicine and Collaborators to Present New Clinical Data Supporting Comprehensive Genomic Profiling in Advanced Sarcomas and Hematologic Malignancies with FoundationOne® Heme
-
Foundation Medicine Announces 2015 Third Quarter Results and Recent Highlights
-
Foundation Medicine Announces Roche Pharmaceuticals (Israel) Ltd. to Commence Commercial Activities in Support of its Molecular Information Products in Oncology
-
Foundation Medicine Announces Timing for Third Quarter 2015 Financial Results and Conference Call
-
Foundation Medicine Launches Precision Medicine Exchange Consortium™ (PMEC) to Advance the Integration of Molecular Information in Clinical Oncology and Accelerate Adoption of Precision Care
-
Foundation Medicine Expands Molecular Information Decision Support Offerings with GeneKit™, a Genomic Solutions Portal for Pathologists
-
Foundation Medicine to Present at Morgan Stanley Global Healthcare Conference
-
Foundation Medicine to Webcast Investor & Analyst Day
-
Foundation Medicine to Present at Wedbush PacGrow Healthcare Conference
-
Foundation Medicine Announces 2015 Second Quarter Results and Recent Highlights
-
Foundation Medicine Initiates Multi-Center Clinical Study Evaluating Its Circulating Tumor DNA (ctDNA) Assay in Multiple Tumor Types
-
University of Colorado Cancer Center and Loxo Oncology Announce Publication That Provides Clinical Validation For LOXO-101 Against TRK Fusion Cancer
-
Foundation Medicine Announces Timing for Second Quarter 2015 Financial Results and Conference Call
-
IMS Health and Foundation Medicine Announce Collaboration to Optimize Targeting of Precision Therapies in Oncology
-
Foundation Medicine to Present at Upcoming Investor Conferences
-
Foundation Medicine Identifies Patients Likely to Respond to Certain MET Inhibitor Targeted Therapies; Durable Responses in Non-Small Cell Lung Cancer (NSCLC) Presented at ASCO Annual Meeting
-
Comprehensive Genomic Profiling with FoundationOne® Guides Targeted Therapeutic Choices and Clinical Responses in Challenging Biliary Tract Cancers
-
New Data Demonstrate Improved Patient Outcomes with Matched Cancer Therapy Informed by Comprehensive Genomic Profiling with FoundationOne®
-
Foundation Medicine and Collaborators to Present Data in 22 Oral and Poster Presentations at the 2015 ASCO Annual Meeting
-
Foundation Medicine's Comprehensive Genomic Profile Informs Therapeutic Choices and Leads to Promising Outcomes in Pediatric Patients With Gliomas
-
Foundation Medicine Announces 2015 First Quarter Results and Recent Highlights
-
Foundation Medicine to Present at Upcoming Investor Conferences
-
Foundation Medicine and Collaborators to Present New Data in 12 Oral and Poster Presentations at the AACR Annual Meeting
-
Foundation Medicine Announces Its Collaboration with the National Cancer Institute on Exceptional Responders Initiative
-
Foundation Medicine Announces Timing for First Quarter 2015 Financial Results and Conference Call
-
Foundation Medicine and Roche Complete Strategic Transaction to Advance Molecular Information and Precision Medicine in Oncology
-
Foundation Medicine Stockholders Approve Pending Roche Transaction at Special Meeting of Stockholders
-
Foundation Medicine and Collaborators to Present New Data in 20 Oral and Poster Presentations at the 2015 USCAP Annual Meeting
-
Foundation Medicine Announces Executive Promotions and Expanded Leadership Team to Complement Global Growth Initiatives
-
Foundation Medicine Announces Proposed Changes to its Board of Directors in Connection with the Pending Roche Transaction
-
Foundation Medicine, Inc. [FMI] to Ring The NASDAQ Stock Market Opening Bell

